Elimination of wild-type P53 mRNA in glioblastomas
Author Information
Author(s): Szybka M, Zawlik I, Kulczycka D, Golanska E, Jesien E, Kupnicka D, Stawski R, Piaskowski S, Bieniek E, Zakrzewska M, Kordek R, Liberski P P, Rieske P
Primary Institution: Medical University of Lodz
Hypothesis
What mechanisms are responsible for favouring the mutated P53 mRNA over the wild-type ones in glioblastomas with heterozygous mutations?
Conclusion
The study suggests that glioblastomas with heterozygous mutations of P53 may have mechanisms that eliminate wild-type P53 mRNA.
Supporting Evidence
- Five glioblastomas showed heterozygous mutations, while three were putatively heterozygous.
- Six of these eight glioblastomas showed elimination of wild-type P53 mRNA.
- The study suggests mechanisms that may silence wild-type P53 transcription or degrade wild-type P53 mRNA.
Takeaway
Some brain tumors called glioblastomas can get rid of normal P53 mRNA and only keep the mutated version, which might help them grow.
Methodology
The study involved screening 50 glioblastoma samples for P53 mutations and analyzing the presence of wild-type and mutated P53 mRNA.
Limitations
The study could not exclude possible contamination of tumor specimens with normal cells in some cases.
Participant Demographics
The sample included 25 females and 25 males, aged from 15 to 76 years (median 59.5).
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website